# Home Hospital for Lymphoma

> **NCT04423848** · NA · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 3 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **OTHER:** Home Hospital for Lymphoma

## Key facts

- **NCT ID:** NCT04423848
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-01-30
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study halted prematurely and will not resume due to poor accrual.
- **Last updated:** 2022-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04423848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04423848, "Home Hospital for Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04423848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*